Peritoneal carcinomatosis of colorectal origin.

作者: Antonio Macrì , Edoardo Saladino , Vincenzo Bartolo , Vincenzo Adamo , Giuseppe Altavilla

DOI: 10.4251/WJGO.V2.I2.98

关键词: MedicineColorectal cancerCytoreductive surgeryHyperthermic intraperitoneal chemotherapyCause of deathStage ivPeritoneal carcinomatosisPeritoneal surfaceSurgery

摘要: Peritoneal carcinomatosis is, after liver metastases, the second most frequent cause of death in colorectal cancer patients and at present time, is commonly inserted treated as a stage IV tumour. Because there no published data that outlines impact new therapeutic regimens on survival with peritoneal surface diffusion, story can be rewritten light aggressive approach based combination cytoreductive surgery hyperthermic intraperitoneal chemotherapy. Also if these treatment perhaps allow to obtain better results than standard therapies, we suggest, large prospective randomised control trial needed compare long-term progression-free under best available systemic therapy or without

参考文章(31)
Griffiths Ct, Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. National Cancer Institute monograph. ,vol. 42, pp. 101- 104 ,(1975)
John McKeown, John S. Spratt, Marie Muskovin, William Sherrill, Robert A. Adcock, Clinical Delivery System for Intraperitoneal Hyperthermic Chemotherapy Cancer Research. ,vol. 40, pp. 256- 260 ,(1980)
Shigeki Kusamura, Elias Dominique, Dario Baratti, Rami Younan, Marcello Deraco, Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. Journal of Surgical Oncology. ,vol. 98, pp. 247- 252 ,(2008) , 10.1002/JSO.21051
Tristan D. Yan, Matthew Links, Sal Fransi, Theresa Jacques, Deborah Black, Vanessa Saunders, David L. Morris, Learning Curve for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy—A Journey to Becoming a Nationally Funded Peritonectomy Center Annals of Surgical Oncology. ,vol. 14, pp. 2270- 2280 ,(2007) , 10.1245/S10434-007-9406-8
Pierre Jacquet, Andrew Averbach, O. Anthony Stuart, David Chang, Paul H. Sugarbaker, Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemotherapy and Pharmacology. ,vol. 41, pp. 147- 154 ,(1997) , 10.1007/S002800050721
Vic J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot, Frans A.N. Zoetmulder, Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer Journal of Clinical Oncology. ,vol. 21, pp. 3737- 3743 ,(2003) , 10.1200/JCO.2003.04.187
Shigeru Fujimoto, Makoto Takahashi, Kokuriki Kobayashi, Masanobu Kure, Takaaki Mutou, Hiroshi Masaoka, Harm Ohkubo, Relation between clinical and histologic outcome of intraperitoneal hyperthermic perfusion for patients with gastric cancer and peritoneal metastasis. Oncology. ,vol. 50, pp. 338- 343 ,(1993) , 10.1159/000227206
A.J. Witkamp, E. de Bree, M.M. Kaag, H. Boot, J.H. Beijnen, G.W. van Slooten, F. van Coevorden, F.A.N. Zoetmulder, Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin European Journal of Cancer. ,vol. 37, pp. 979- 984 ,(2001) , 10.1016/S0959-8049(01)00058-2
Santiago González-Moreno, Peritoneal Surface Oncology: A progress report Ejso. ,vol. 32, pp. 593- 596 ,(2006) , 10.1016/J.EJSO.2006.03.001
P. H. Sugarbaker, Management of peritoneal-surface malignancy: the surgeon’s role Langenbeck's Archives of Surgery. ,vol. 384, pp. 576- 587 ,(1999) , 10.1007/S004230050246